Pfizer yesterday got approval for Palladia to treat advanced mast cell tumours in dogs, the first of its kind for treating cancer in canines. Researchers at Pfizer recruited around 150 dogs for the pivotal pet study, and observed that Palladia caused reduction or disappearance of tumours in 43 percent of cases. Less than one in ten dogs in the placebo arm had a similar response in the said pivotal trial. I think that it is high time for Indian biopharmaceuticals as they can strategise and focus on venturing into these specialized segment, thus diversifying their services to the society.
Friday, June 05, 2009
Pfizer......Cancer drug for Pets........
Pfizer yesterday got approval for Palladia to treat advanced mast cell tumours in dogs, the first of its kind for treating cancer in canines. Researchers at Pfizer recruited around 150 dogs for the pivotal pet study, and observed that Palladia caused reduction or disappearance of tumours in 43 percent of cases. Less than one in ten dogs in the placebo arm had a similar response in the said pivotal trial. I think that it is high time for Indian biopharmaceuticals as they can strategise and focus on venturing into these specialized segment, thus diversifying their services to the society.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment